Sana Biotechnology Analyst Ratings
Sana Biotechnology Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/25/2023 | 134.99% | JMP Securities | → $9 | Initiates Coverage On | → Market Outperform |
| 09/05/2023 | 108.88% | Citigroup | → $8 | Initiates Coverage On | → Buy |
| 08/14/2023 | — | TD Cowen | Initiates Coverage On | → Market Perform | |
| 05/02/2023 | — | HC Wainwright & Co. | Initiates Coverage On | → Neutral | |
| 01/24/2023 | 239.43% | Morgan Stanley | $15 → $13 | Maintains | Overweight |
| 11/03/2022 | 56.66% | Goldman Sachs | $7 → $6 | Maintains | Neutral |
| 05/17/2022 | 291.64% | Morgan Stanley | $17 → $15 | Maintains | Overweight |
| 08/06/2021 | 787.73% | Goldman Sachs | $39 → $34 | Maintains | Neutral |
| 03/01/2021 | 813.84% | JP Morgan | → $35 | Initiates Coverage On | → Neutral |
| 03/01/2021 | 944.39% | Morgan Stanley | → $40 | Initiates Coverage On | → Overweight |
| 03/01/2021 | 944.39% | Goldman Sachs | → $40 | Initiates Coverage On | → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/25/2023 | 134.99% | JMP證券 | →$9 | 開始承保 | →市場跑贏大盤 |
| 09/05/2023 | 108.88% | 花旗集團 | →$8 | 開始承保 | →購買 |
| 2023年08月14日 | - | TD Cowen | 開始承保 | →市場表現 | |
| 05/02/2023 | - | HC Wainwright公司 | 開始承保 | →中性 | |
| 01/24/2023 | 239.43% | 摩根士丹利 | $15→$13 | 維護 | 超重 |
| 11/03/2022 | 56.66% | 高盛 | $7→$6 | 維護 | 中性 |
| 2022/05/17 | 291.64% | 摩根士丹利 | $17→$15 | 維護 | 超重 |
| 08/06/2021 | 787.73% | 高盛 | $39→$34 | 維護 | 中性 |
| 03/01/2021 | 813.84% | 摩根大通 | →$35 | 開始承保 | →中性 |
| 03/01/2021 | 944.39% | 摩根士丹利 | →$40 | 開始承保 | →超重 |
| 03/01/2021 | 944.39% | 高盛 | →$40 | 開始承保 | →中性 |
What is the target price for Sana Biotechnology (SANA)?
Sana Biotech(SANA)的目標價是多少？
The latest price target for Sana Biotechnology (NASDAQ: SANA) was reported by JMP Securities on September 25, 2023. The analyst firm set a price target for $9.00 expecting SANA to rise to within 12 months (a possible 134.99% upside). 6 analyst firms have reported ratings in the last year.
納斯達克(Sana Biotech)的最新目標價於2023年9月25日由摩根大通證券公佈。這家分析公司將目標價定為9美元，預計SANA將在12個月內上漲(可能上漲134.99%)。6家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Sana Biotechnology (SANA)?
薩那生物科技(SANA)的最新分析師評級是多少？
The latest analyst rating for Sana Biotechnology (NASDAQ: SANA) was provided by JMP Securities, and Sana Biotechnology initiated their market outperform rating.
納斯達克(Sana Biotech)的最新分析師評級是由摩根大通證券提供的，Sana Biotech發起了其表現優於大盤的評級。
When is the next analyst rating going to be posted or updated for Sana Biotechnology (SANA)?
薩那生物科技(SANA)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sana Biotechnology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sana Biotechnology was filed on September 25, 2023 so you should expect the next rating to be made available sometime around September 25, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Sana Biotech的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Sana Biotech的上一次評級是在2023年9月25日提交的，所以你應該預計下一次評級將在2024年9月25日左右的某個時候公佈。
Is the Analyst Rating Sana Biotechnology (SANA) correct?
分析師對Sana Biotech(SANA)的評級正確嗎？
While ratings are subjective and will change, the latest Sana Biotechnology (SANA) rating was a initiated with a price target of $0.00 to $9.00. The current price Sana Biotechnology (SANA) is trading at is $3.83, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的薩那生物技術(SANA)評級是以0.00美元至9.00美元的目標價啟動的。Sana Biotech(SANA)目前的交易價格為3.83美元，在分析師的預測範圍內。